Preparation and radiolabeling of a lyophilized (kit) formulation of DOTA-rituximab with (90)Y and (111)In for domestic radioimmunotherapy and radioscintigraphy of Non-Hodgkin’s Lymphoma

BACKGROUND: On the basis of results of our previous investigations on (90)Y-DTPA-rituximab and in order to fulfil national demands to radioimmunoconjugates for radioscintigraphy and radioimmunotherapy of Non-Hodgkin’s Lymphoma (NHL), preparation and radiolabeling of a lyophilized formulation (kit) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gholipour, Nazila, Jalilian, Amir Reza, Khalaj, Ali, Johari-Daha, Fariba, Yavari, Kamal, Sabzevari, Omid, Khanchi, Ali Reza, Akhlaghi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261883/
https://www.ncbi.nlm.nih.gov/pubmed/25074720
http://dx.doi.org/10.1186/2008-2231-22-58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261883/
https://www.ncbi.nlm.nih.gov/pubmed/25074720
http://dx.doi.org/10.1186/2008-2231-22-58

Ejemplares similares